Share this:
Published on: May 19, 2021 at 12:00PM
Condition: Recurrent Thyroid Cancer
Intervention: Combination Product: Combination treatment (CXRPT) of external beam radiation (XRT) plus radioactive iodine (RAI)
Sponsors: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins; National Cancer Institute (NCI)
Recruiting
https://ift.tt/2Qv7U8P
More Stories
New cancer clinical trial: Cetuximab Sensitivity Correlation Between Patient-Derived Organoids and Clinical Response in Colon Cancer Patients.
New cancer clinical trial: Onco-liq: Kit for Breast Cancer Diagnosis.
New cancer clinical trial: PERformance of Multi-Cancer Early-detectIon Based on Various Biomarkers in fEmale Cancers, PERCEIVE-I